Company Profile
Wuhan Sunrise Technology Development Company limited was established in 2008. We are specialized in producing and exporting pharmaceuticals,pharmaceutical intermediates and fine chemicals . Also we can make contract production for pharmaceutical companies with quantities from grams to tons.We have one lab in Shanghai, one lab in Beijing and one factory in Jiangshu Lianyungang. We also have close cooperation with some GMP ceritified pharmaceutical factories,some Universities and Research Institutes .Our products are well sold not only across our China but also into many European, American and southeast Asia countries. We are striving to offer all our customers excellent service, excellent business and excellent price.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole |
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole;6-Iodo-3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-Indazole;(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole;(E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl);6-iodo-3-((E)-2-(pyridin-2-yl-vinyl)-1-(tetrahydropyran-2-yl)-1H-indazole;6-iodo-1-(oxan-2-yl)-3-(2-pyridin-2-ylethenyl)indazole;6-Iodo-3-(2-pyridin-2-yl-vinyl)-1-(tetrahydro-pyran-2-yl)-1H-indazole |
886230-77-9 | Inquiry | |
(S)-(+)-GLYCIDYL PHTHALIMIDE |
1H-Isoindole-1,3(2H)-dione,2-[(2S)-2-oxiranylmethyl]-;1H-Isoindole-1,3(2H)-dione,2-(oxiranylmethyl)-,(S)-;1H-Isoindole-1,3(2H)-dione,2-[(2S)-oxiranylmethyl]-;2-[(2S)-2-Oxiranylmethyl]-1H-isoindole-1,3(2H)-dione;N-((2S)-Oxiran-2-ylmethyl)phthalimide;2-[(S)-2-Oxiranylmethyl]-1H-isoindol-1,3(2H)-dione;N-(S)-Glycidylphthalimide;(S)-N-(2,3-Epoxypropan-1-yl)phthalimide;(S)-2-[(Oxiranyl)methyl]isoindole-1,3-dione;(S)-N-(2,3-Epoxypropyl)phthalimide;(S)-2-(Oxiran-2-ylmethyl)-1H-isoindole-1,3(2H)-dione;N-[(+)-Glycidyl]phthalimide;N-[(S)-(+)-Glycidyl]phthalimide;(S)-Glycidyl Phthalimide;(S)-N-Giycidylphthalimide;(S)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione;(S)-N-Glycidylphthalimide;2-[[(2S)-Oxiran-2-yl]methyl]isoindole-1,3-dione |
161596-47-0 | Inquiry | |
(S)-N-Acetylleucine |
L-Leucine,N-acetyl-;Leucine,N-acetyl-,L-;N-Acetyl-L-leucine;N-Acetylleucine;Acetyl-L-leucine;N-Acetyl-L-(-)-leucine;Acetylleucine;NSC 206316;(S)-2-Acetamido-4-methylpentanoic acid;(-)-N-Acetyl-L-leucine;(2S)-2-Acetamido-4-methylpentanoic acid;24160-46-1;90243-88-2 |
1188-21-2 | Inquiry | |
170729-80-3 |
3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-;3H-1,2,4-Triazol-3-one,5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,[2R-[2α(R*),3α]]-;5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one;L 754030;MK 869;Aprepitant;MK 0869;Emend;ONO 7436;221350-96-5 |
170729-80-3 | Inquiry | |
3b,5-Dihydroxy-6b,7b:15b,16b-dimethylene-5b-androstan-17-one |
17H-Dicyclopropa[6,7:15,16]cyclopenta[a]phenanthren-17-one,octadecahydro-3,5-dihydroxy-10,13-dimethyl-,(3S,5R,6R,7R,8R,9S,10R,13S,14S,15S,16S)-;17H-Dicyclopropa[6,7:15,16]cyclopenta[a]phenanthren-17-one,octadecahydro-3,5-dihydroxy-10,13-dimethyl-,[3S-(3α,5α,6β,7β,8α,9β,10α,13α,14β,15β,16β)]-;(3S,5R,6R,7R,8R,9S,10R,13S,14S,15S,16S)-Octadecahydro-3,5-dihydroxy-10,13-dimethyl-17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthren-17-one;6β,7β15β,16β-Dimethylene-3β,5β-dihydroxyandostan-17-one;3β,5β-Dihydroxy-6β,7β15β,16β-dimethylene-5β-androst-17-one |
82543-16-6 | Inquiry | |
4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- |
4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-;N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4-quinazolinamine;(S)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-(tetrahydrofuran-3-yloxy)quinazolin-4-amine |
314771-88-5 | Inquiry | |
5,6,7,7a-Tetrahydro-5-(triphenylmethyl)thieno[3,2-c]pyridinone |
5,6,7,7a-Tetrahydro-5-(triphenylmethyl)thieno[3,2-c]pyridin-2(4H)-one;5,6,7,7a-Tetrahydro-5-(triphenylmethyl)thieno[3,2-c]pyridinone;5-Trityl-5,6,7,7a-tetrahydrothieno-[3,2-c]pyridin-2(4H)-one;Thieno[3,2-c]pyridin-2(4H)-one,5,6,7,7a-tetrahydro-5-(triphenylMethyl)-;Prasugrel Intermediate 3;5-trityl-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(3H)-one |
109904-26-9 | Inquiry | |
5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide |
1H-Benzimidazole-6-carboxamide,5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-;5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide;ARRY 142886;AZD 6244;Selumetinib;NSC 741O78;G 00039805;6-(4-Bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide;Koselugo;AZD6244;AZD-6244;865610-79-3 |
606143-52-6 | Inquiry | |
6-FLUORO-3-(4-PIPERIDINYL)-1,2-BENZISOXAZOLE |
1,2-Benzisoxazole,6-fluoro-3-(4-piperidinyl)-,hydrochloride (1:1);1,2-Benzisoxazole,6-fluoro-3-(4-piperidinyl)-,monohydrochloride;4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidine hydrochloride;6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride;6-Fluoro-3-(4-piperidinyl)benzisoxazole hydrochloride;6-Fluoro-3-(piperidin-4-yl)benzo[d]isoxazole hydrochloride;6-Fluoro-3-(piperidinyl-4-yl)-benzisoxazole hydrochloride;6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole monohydrochloride |
84163-13-3 | Inquiry | |
8-CHLORO-6,11-DIHYDRO-11-[1-[(5-METHYL-3-PYRIDYL)METHYL]-4-PIPERIDYLIDENE]-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE FUMARATE |
5H-Benzo[5,6]cyclohepta[1,2-b]pyridine,8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene]-,(2E)-2-butenedioate (1:1);5H-Benzo[5,6]cyclohepta[1,2-b]pyridine,8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene]-,(E)-2-butenedioate (1:1);Rupatadine fumarate |
182349-12-8 | Inquiry | |
ACLIDINIUM BROMIDE |
1-Azoniabicyclo[2.2.2]octane,3-[(2-hydroxy-2,2-di-2-thienylacetyl)oxy]-1-(3-phenoxypropyl)-,bromide (1:1),(3R)-;1-Azoniabicyclo[2.2.2]octane,3-[(hydroxydi-2-thienylacetyl)oxy]-1-(3-phenoxypropyl)-,bromide,(3R)-;Aclidinium bromide;LAS 34273;LAS-W 330;(3R)-(2-Hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide;Genuair;Eklira Genuair;Bretaris Genuair |
320345-99-1 | Inquiry | |
adaliMuMab |
Adalimumab;D2E7;Humira;Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer;Unii-fys6T7F842;LU200134;Adalimumab (anti-TNF-alpha);Unii-fys6T7F842 USP/EP/BP |
331731-18-1 | Inquiry | |
Alogliptin benzoate |
Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-,benzoate (1:1);Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-,monobenzoate;SYR 322;Alogliptin benzoate;Nesina;865720-54-3 |
850649-62-6 | Inquiry | |
ANIDULAFUNGIN |
166663-25-8 | Inquiry | ||
avanafil |
5-Pyrimidinecarboxamide,4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-;4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;(S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[N-(2-pyrimidinylmethyl)carbamoyl]pyrimidine;TA 1790;Avanafil;(S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;Spedra;330785-17-6;647841-09-6 |
330784-47-9 | Inquiry | |
Bimatoprost |
5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-,(5Z)-;5-Heptenamide,7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-,[1R-[1α(Z),2β(1E,3S*),3α,5α]]-;5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-,(5Z)-;(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide;Bimatoprost;AGN 192024;Lumigan;Prostamide;Latisse;17-Phenyltrinor-PGF2α ethylamide;267244-98-4 |
155206-00-1 | Inquiry | |
Cabazitaxel |
Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,(αR,βS)-;Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,[2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-;TXD 258;Cabazitaxel;XRP 6258;Jevtana;DEP cabazitaxel;890654-44-1 |
183133-96-2 | Inquiry | |
Canagliflozin |
D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-,(1S)-;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;TA 7284;JNJ 28431754;Canagliflozin;JNJ 28431754AAA;JNJ 24831754ZAE;Invokana;1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;2169850-08-0 |
842133-18-0 | Inquiry | |
Cetuximab |
CETUXIMAB;Erbitux;Hsdb 7454;Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer;Unii-pqx0D8J21j;EGFR antibody;IMC 225;CetuxiMab(C225) |
205923-56-4 | Inquiry | |
Combretastatin A4 |
Phenol,2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-;Phenol,2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]-,(Z)-;2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol;Combretastatin A4;NSC 817373;CRC 87-09;NSC 613729;Combretastatin 4;CA 4;2′-Deoxycombretastatin A1;2-Methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol;cis-Combretastatin A4;Cis-Combretastatin A4;C 7744;848866-48-8;1052086-67-5 |
117048-59-6 | Inquiry |
CONTACT INFORMATION
Sign In for Details